This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:17396/feed
ISSN 2327-2236
Infectious Diseases
Vol. 1, Issue 2, 2013October 08, 2013 EDT

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States

Emily Durden, Donna McMorrow, Paul Juneau, Robert Fowler, Paresh Chaudhari, David Horn,
treatmentcostsburdeneconomicaspergillosis
Copyright Logoccby-4.0 • https://doi.org/10.36469/9862
JHEOR
1.
Durden E, McMorrow D, Juneau P, Fowler R, Chaudhari P, Horn D. Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States. JHEOR. 2013;1(2):151-162. doi:10.36469/​9862

View more stats

Powered by Scholastica, the modern academic journal management system